Washington University School of Medicine has received a $61 million grant renewal for its Institute of Clinical and Translational Sciences to support clinical and translational research across the region.
Michael Nowak, research professor of physics in Arts & Sciences, is part of the global research team that shared the first image of the supermassive black hole at the center of our own Milky Way galaxy.
Andrea Soranno, Kathleen Hall and Alex Holehouse, all at the School of Medicine, received a new five-year $3.1 million grant from the National Institutes of Health (NIH) to research genome packaging of the virus that causes COVID-19.
Researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine have found a way to help more patients who want to stop smoking. The successful strategy involves using electronic medical records to help identify smokers when they visit their oncologists and offering help with quitting during such visits.
Several distinguished speakers, faculty members and student leaders will take part in Commencement recognition ceremonies for Class of 2022 graduates and their families and guests May 18-20 at Washington University in St. Louis.
Using the properties of a unique class of materials, researchers, including Aravind Nagulu at the McKelvey School of Engineering, may have found a way to dramatically increase the bandwidth available for wireless communications.
Russia’s war in Ukraine has displaced millions of people, most of them women and children. This mounting crisis suggests that conflict-related sexual violence, which has been reported in Ukraine, requires urgent action, say Washington University in St. Louis experts on refugees and displaced populations.
Ethan Lowder, a December 2021 graduate who majored in the biochemistry track of biology in Arts & Sciences, won the Ralph S. Quatrano Prize; Kayla Wallace, a senior majoring in environmental biology with a minor in anthropology in Arts & Sciences, received the Spector Prize.
Researchers at Washington University School of Medicine and Saint Louis University found that less than half of Americans who received treatment for opioid use disorder over a five-year period were offered a potentially lifesaving medication.
